...
首页> 外文期刊>Drug and alcohol review >Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
【24h】

Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.

机译:澳大利亚甲基苯丙胺戒断治疗的障碍:对AOD服务提供商的调查结果。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION AND AIMS: Despite the high prevalence of methamphetamine use and dependence in Australia, withdrawal treatment access for methamphetamine accounts for only 9.3% of total withdrawal treatment presentations. Furthermore, treatment completion for methamphetamine users is one of the lowest of all drugs. There is not a clear understanding for the reasons why methamphetamine withdrawal treatment presentations and efficacy is so low. This study examined the current practices and barriers to methamphetamine withdrawal treatment in Australia. DESIGN AND METHODS: Twenty-four interviews were conducted with employees from alcohol and other drug services from around Australia. These services were questioned about a range of issues relating to methamphetamine withdrawal treatment including current treatment practices, perception of the effectiveness of current treatment and barriers to treatment. RESULTS: The study found that current practices in the treatment of methamphetamine withdrawal are diverse and uncertain. Service providers identified a great number of barriers to the treatment of methamphetamine withdrawal that encompass personal, social, cultural and organisational barriers. DISCUSSION AND CONCLUSIONS: The results of this study suggest that alcohol and other drug service providers are not clear about the best way to respond to clients seeking methamphetamine withdrawal treatment. Furthermore, the study showed a general pessimism about withdrawal treatment for this group. Treatment services should consider improving withdrawal protocols, educating clinicians and reconsidering entry criteria to better respond to methamphetamine users who have made the important first step into withdrawal treatment.
机译:引言和目的:尽管在澳大利亚甲基苯丙胺的使用和依赖性很高,但是甲基苯丙胺的戒断治疗仅占总戒断治疗的9.3%。此外,甲基苯丙胺使用者的治疗完成率是所有药物中最低的之一。由于甲基苯丙胺戒断治疗的表现和疗效如此低的原因,目前尚无明确的认识。这项研究检查了澳大利亚目前的甲基苯丙胺戒断治疗的做法和障碍。设计与方法:对来自澳大利亚各地的酒精及其他毒品服务业的雇员进行了二十四次访谈。这些服务被问到与甲基苯丙胺戒断治疗有关的一系列问题,包括当前治疗方法,对当前治疗效果的认识以及治疗障碍。结果:研究发现,目前在甲基苯丙胺戒断治疗中的实践是多种多样的,并且不确定。服务提供商发现了甲基苯丙胺戒断治疗的诸多障碍,其中包括个人,社会,文化和组织方面的障碍。讨论与结论:这项研究的结果表明,酒精和其他毒品服务提供者尚不清楚对寻求甲基苯丙胺戒断治疗的患者做出反应的最佳方法。此外,研究表明,该组对戒断治疗普遍感到悲观。治疗服务机构应考虑改善戒断方案,对临床医生进行培训,并重新考虑入院标准,以更好地应对已成为戒断治疗重要第一步的甲基苯丙胺使用者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号